Cosmofarma SRL
8.1 FTECosmofarma reported total assets of €5.34m at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Sep 2026), with 8.1 full-time equivalents.
The score of Cosmofarma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +79 % Total assets +58 % Headcount (avg FTE) -38 %
Accounts of the company itself (not consolidated).
The full file covers 12 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Cosmofarma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Sep 2026
- Year ended 31 Dec 2024filed on 29 Sep 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 29 Sep 2023
- Year ended 31 Dec 2021filed on 23 Sep 2022
Cosmofarma's financial analysis
- Solvency21.6%sector median: 31.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Cosmofarma
Cosmofarma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0466.198.034
- VAT number
- BE0466198034
- Peppol
- Registered · 0208:0466198034 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Jun 1999
- Registered office
- 9900 Eeklo
- Size
- Micro · 8.1 FTE
- Latest accounts
- 2025 · filed on 30 Sep 2026
- Activity
- Manufacture of perfume and toilet preparations (NACE 20420)
Cosmofarma (SRL) has been based in Eeklo since 1999, active in: manufacture of perfume and toilet preparations. For 2025, it reports a net profit of 4,180 € and equity of €1.15m; its revenue is not published. With 8.1 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 21.6%, below the median of its sector (31.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Cosmofarma
Companies in the same business, of comparable size and area, outside its group.
- Eytelia Manufacture of homogenised food preparations and dietetic food Fleurus · balance sheet €4.81m
- Scentarom Manufacture of other food products n.e.c. Merchtem · balance sheet €6.24m
- Professionails Wholesale of perfume and cosmetics Brasschaat · balance sheet €5.41m
- Puressentiel Benelux Wholesale of perfume and cosmetics Ixelles · balance sheet €5.35m
- Senitas Wholesale of perfume and cosmetics Diepenbeek · balance sheet €4.82m
- Soria Bel Wholesale of other food Ichtegem · balance sheet €3.11m
- Herbalife International Belgium Wholesale of other food Brussels · balance sheet €11.0m
- Cressana Manufacture of other food products n.e.c. Zwalm · balance sheet €3.34m
Frequently asked questions about Cosmofarma
What is the revenue of Cosmofarma?
Cosmofarma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Cosmofarma?
In Belgium, the VAT number is the company number prefixed with BE: BE0466198034 for Cosmofarma, if the company is VAT-registered. Its company number (CBE) is 0466.198.034.
Where is the registered office of Cosmofarma?
According to the CBE register, the registered office of Cosmofarma is in 9900 Eeklo.
What is the equity of Cosmofarma?
At the close of the 2025 financial year, the equity of Cosmofarma amounts to 1,153,119 €, a solvency of 21.6% of total assets.
How many people work at Cosmofarma?
8.1 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Cosmofarma?
The register lists 3 active mandates at Cosmofarma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Cosmofarma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →